Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Investment

HESTA injects $4.4m into Aussie biotech startup

Sydney-based Inventia Life Science has announced the super fund's direct investment as it develops, manufactures and distributes the RASTRUM 3D bioprinter.

Upgrade your subscription to access this article

And gain access to:
  • All archived news content
  • Access to the Financial Standard app
  • Home page news customisation
  • Financial Standard 's fortnightly newspaper
  • 25% discount on tickets to networking events
And more
Already A Subscriber?

Read more: HESTAInventia Life ScienceJulio RibeiroSonya Sawtell-RicksonAidan Mahony